Skip to content
michaelskylion's profile image - click for profile

Michael Skylion's Fundraiser:

Genosans - Cancer Treatment Project

Michael's Photo
Michael Skylion


The Genosans is a cancer treatment drug, which has been developed to treat patients with different forms and at different stages of oncopathology cancer. This new product allows patients to achieve a full recovery. The drug’s low toxicity, relatively low-cost and easiness of administrations, paved the way to the new prospects of treatment and diagnosis of cancer pathology at the Global scale.

The Genosans has no analogues in the world on the mechanisms of realization and results. According to the existing data of the clinical trials of the drug on volunteers, 86% of patients disregarding the stage of development and cancer localization have achieved a complete recovery from the disease. The monitoring period for the volunteers in remission is now more than 10 years and none have reported any issues or complains about the treatment.

The necessity funding is estimated about $3,000,000. The project phases described below:
• Phase I is a pre-clinical and clinical certification of the cancer treatment drug Genosans. The pre-clinical phase of drug testing using laboratory animals is estimated at $50,000. The clinical phase of the certification is estimated at about $ 200,000.
• Phase II is the production of the cancer treatment drug Genosans in the required quantities for testing and usage. It requires about $ 1.75 million (excluding the cost of raw materials) in order to establish the drug’s production line on the industrial scale.
• Phase III is the distribution of the cancer treatment drug Genosans to patients with different cancer stages and localization on the Global scale. It is all about marketing and establishing the distribution channels of Genosans in order to deliver the drug directly to the leading Oncology Centers (local and foreign) and other medical institutions which provide the treatment of cancer pathology. The cost of this phase is estimated to be about $ 1,000,000.

Preliminary studies confirm the efficiency of cancer treatment. The recovery of over a hundred terminally ill volunteers (3rd, 4th stages of cancer) is the most substantial result of new drug’s application.
The scientific research of Genosans has demonstrated drug’s lack of toxicity.



Want to help Fundraise or Volunteer for this amazing Fundraiser? Join the Team

Donor Comments

Be the first to Donate to Michael and Genosans - Cancer Treatment Project.